| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1112.57 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 1110.73 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1145.45 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 949.737 | 95 |
| GSM780720 | Untreated after 4 days (C2_2) | 1055.08 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1164.55 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 930.121 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 909.854 | 95 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1050.63 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1117.36 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 972.517 | 95 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1053.91 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1112.57 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1159.97 | 96 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1069.99 | 96 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1078.86 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1037.55 | 96 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1028.73 | 96 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 954.197 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1262.85 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1038.04 | 96 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 864.393 | 95 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1110.73 | 96 |